Two months after its launch, Havas Health & You cannabis specialty agency Havas ECS is launching a medical education program with a focus on cannabinoids. 

The program is its first step in closing the knowledge gap about cannabinoids and the endocannabinoid system. Its goal is to reach the medical and legal communities to educate them on CBD, its products and the liabilities around it.

The education program is called Medical Cannabis: The Science. The Research. The Risks. It is set to start with a conference in New York City on November 15 in partnership with the American Journal of Endocannabinoid Medicine (AJEM), Connect Medical Legal Experts, Everyday Health and MedPage Today. The conference lineup features conversations about the endocannabinoid system, drug and disease interactions and the legal issues around CBD.

One part of the conference will be a mock trial to highlight a potential real-life scenario in which a fatal accident occurs. The mock trial will star former NFL player Marvin Washington and feature two trial lawyers, a doctor, a patient and a cannabis product — and the audience will decide which party is at fault. 

Industry and medical experts set to speak at the conference include: Philipe Lucas, VP patient research and access at Tilray; Dr. Margaret Haney, professor of Neurobiology at Columbia University Medical Center; Lauren Rudick, attorney at Hiller PC New York and member of the National Cannabis Bar Association; and Dr. Jahan Marcu, editor-in-chief of AJEM.